1. Home
  2. TOWN vs IBRX Comparison

TOWN vs IBRX Comparison

Compare TOWN & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$35.17

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$5.47

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
IBRX
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
TOWN
IBRX
Price
$35.17
$5.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$41.00
$11.50
AVG Volume (30 Days)
377.2K
18.5M
Earning Date
01-22-2026
03-02-2026
Dividend Yield
3.06%
N/A
EPS Growth
11.95
N/A
EPS
2.23
N/A
Revenue
$766,599,000.00
$82,555,000.00
Revenue This Year
$23.63
$667.58
Revenue Next Year
$29.20
$92.92
P/E Ratio
$15.82
N/A
Revenue Growth
14.10
1025.95
52 Week Low
$29.43
$1.83
52 Week High
$38.01
$4.27

Technical Indicators

Market Signals
Indicator
TOWN
IBRX
Relative Strength Index (RSI) 57.17 92.86
Support Level $33.84 $1.95
Resistance Level $35.53 $2.29
Average True Range (ATR) 0.74 0.28
MACD 0.08 0.30
Stochastic Oscillator 83.58 98.48

Price Performance

Historical Comparison
TOWN
IBRX

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: